Flunarizine
Phase 3Small molecule
Flunarizine is one of 38 small molecule programs targeting Migraine. It is currently in Phase 3.
1
Indications
12
Total Trials
5
Active Trials
37
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
102 competitors in Migraine
#DrugCompanyPhaseTrials
1Zonegran
AAzurity Pharmaceuticals
Phase 3
Avicel
SSanthera Pharmaceuticals
Phase 3
Effient
CCosette Pharmaceuticals, Inc.
Phase 3
Magnesium
SSpherium Biomed
Phase 3
Flunarizine
AAspartes Pharmaceuticals, Inc.
Phase 3
BAT7104
TevaPhase 3
Tizanidine Hydrochloride
EElan Pharmaceuticals
Phase 3
Bayer Aspirin
BayerPreclinical
Cervidil
PfizerPreclinical
Cymbalta
Jazz PharmaceuticalsPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Migraine9 trials
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
Not yet recruiting·FFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina·Phase 4·NCT06499116·460 enrolled
Evaluation of Efficacy and Safety of add-on Alpha-lipoic Acid on Migraine Prophylaxis in Adolescent Population
Completed·—·Phase 4·NCT04064814·60 enrolled
Efficacy of Flunarizine Vs Amitriptyline in Prophylaxis of Migraine Prophylaxis
Unknown status·—·N/A·NCT06162819·84 enrolled
Show 6 more trials
Comparison of Therapeutic Effects of Greater Occipital Nerve Block, Topiramate, and Flunarizine on Episodic Migraine
Completed·—·N/A·NCT03712917·120 enrolled
A Randomized, Open-Label, Multi-Center Study of Vestibular Migraine Prevention: Rimegepant Versus Flunarizine Non-inferiority Study
Not yet recruiting·SSecond Affiliated Hospital, Zhejiang University, School of Medicine·Phase 2·NCT07751497·400 enrolled
Schizophrenia1 trial
Migraine Prophylaxis1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Flunarizine. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- AAspartes Pharmaceuticals, Inc.